Frank Witney
CIK: 0001455312
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jun 18, 2026LAB
STANDARD BIOTOOLS INC.
Award(A)Direct99.1K shares- - Jun 2, 2026CERS
CERUS CORP
Award(A)Direct60K shares- - May 7, 2026RVTY
REVVITY, INC.
Award(A)Direct1K shares- - May 7, 2026RVTY
REVVITY, INC.
Award(A)Direct1.3K shares- - Apr 20, 2026ALMR
Alamar Biosciences, Inc.
Other(J)DirectStock Option (Right to Buy)
49.6K shares- - Apr 20, 2026ALMR
Alamar Biosciences, Inc.
Other(J)DirectStock Option (Right to Buy)
33.1K shares- - Apr 20, 2026ALMR
Alamar Biosciences, Inc.
Other(J)DirectStock Option (Right to Buy)
49.6K shares- - Apr 20, 2026ALMR
Alamar Biosciences, Inc.
Other(J)DirectStock Option (Right to Buy)
124.1K shares- - Apr 20, 2026ALMR
Alamar Biosciences, Inc.
Other(J)DirectStock Option (Right to Buy)
124.1K shares- - Apr 20, 2026ALMR
Alamar Biosciences, Inc.
Other(J)DirectStock Option (Right to Buy)
33.1K shares- - Jun 20, 2025LAB
STANDARD BIOTOOLS INC.
Award(A)Direct94.6K shares- - Jun 3, 2025CERS
CERUS CORP
Award(A)Direct60K shares- - Apr 30, 2025RVTY
REVVITY, INC.
Award(A)Direct1.1K shares- - Apr 30, 2025RVTY
REVVITY, INC.
Award(A)Direct1.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  LAB STANDARD BIOTOOLS INC. | Award(A) | 99,116 | - | $0 | Direct |
| Jun 2, 2026 |  CERS CERUS CORP | Award(A) | 60,000 | - | $0 | Direct |
| May 7, 2026 |  RVTY REVVITY, INC. | Award(A) | 1,015 | - | $0 | Direct |
| May 7, 2026 | RVTY REVVITY, INC. | Award(A) | 1,265 | - | $0 | Direct |
| Apr 20, 2026 |  ALMR Alamar Biosciences, Inc. | Other(J) Stock Option (Right to Buy) | 49,627 | - | - | Direct |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | Other(J) Stock Option (Right to Buy) | 33,085 | - | - | Direct |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | Other(J) Stock Option (Right to Buy) | 49,627 | - | - | Direct |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | Other(J) Stock Option (Right to Buy) | 124,069 | - | - | Direct |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | Other(J) Stock Option (Right to Buy) | 124,069 | - | - | Direct |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | Other(J) Stock Option (Right to Buy) | 33,085 | - | - | Direct |
| Jun 20, 2025 | LAB STANDARD BIOTOOLS INC. | Award(A) | 94,592 | - | - | Direct |
| Jun 3, 2025 | CERS CERUS CORP | Award(A) | 60,000 | - | - | Direct |
| Apr 30, 2025 | RVTY REVVITY, INC. | Award(A) | 1,074 | - | - | Direct |
| Apr 30, 2025 | RVTY REVVITY, INC. | Award(A) | 1,338 | - | - | Direct |
1-14 of 14 transactions
About Witney Frank
Witney Frank (SEC CIK 0001455312) files insider reports with the SEC as Director of STANDARD BIOTOOLS INC. (LAB), Director of CERUS CORP (CERS) and Director of REVVITY, INC. (RVTY). Signal8 also holds filings tied to 1 other company.
Signal8 holds 8 ownership filings by Witney Frank (1 Form 3, 7 Form 4), filed between May 1, 2025 and Jun 23, 2026. Those filings report 14 transactions, from Apr 30, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Witney Frank's filings is in CONCORD, CA.
Recent filings by Witney Frank
- Jun 18, 2026: Grant or award of LAB shares (Form 4, code A).
- Jun 2, 2026: Grant or award of CERS shares (Form 4, code A).
- May 7, 2026: Grants or awards of RVTY shares (2 lines, Form 4, code A).
- Apr 20, 2026: Other transactions of ALMR derivative securities (6 lines, Form 4, code J).
- Jun 20, 2025: Grant or award of LAB shares (Form 4, code A).
Other insiders filing for STANDARD BIOTOOLS INC. (LAB)
- Mackay Sean, SVP & Chief Business Officer
- Kim Hanjoon Alex, Chief Financial Officer
- Egholm Michael, President & CEO
- Carey Thomas D., Director
- Casdin Eli, Director
- Cox Troy, Director